1. Home
  2. HLI vs ALGN Comparison

HLI vs ALGN Comparison

Compare HLI & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLI
  • ALGN
  • Stock Information
  • Founded
  • HLI 1972
  • ALGN 1997
  • Country
  • HLI United States
  • ALGN United States
  • Employees
  • HLI N/A
  • ALGN N/A
  • Industry
  • HLI Investment Managers
  • ALGN Industrial Specialties
  • Sector
  • HLI Finance
  • ALGN Health Care
  • Exchange
  • HLI Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • HLI 13.7B
  • ALGN 12.5B
  • IPO Year
  • HLI 2015
  • ALGN N/A
  • Fundamental
  • Price
  • HLI $195.94
  • ALGN $205.56
  • Analyst Decision
  • HLI Buy
  • ALGN Buy
  • Analyst Count
  • HLI 8
  • ALGN 13
  • Target Price
  • HLI $202.57
  • ALGN $239.33
  • AVG Volume (30 Days)
  • HLI 403.7K
  • ALGN 852.4K
  • Earning Date
  • HLI 07-29-2025
  • ALGN 07-30-2025
  • Dividend Yield
  • HLI 1.22%
  • ALGN N/A
  • EPS Growth
  • HLI 41.61
  • ALGN N/A
  • EPS
  • HLI 5.82
  • ALGN 5.50
  • Revenue
  • HLI $2,389,126,000.00
  • ALGN $3,980,843,000.00
  • Revenue This Year
  • HLI $10.96
  • ALGN $5.73
  • Revenue Next Year
  • HLI $13.16
  • ALGN $5.63
  • P/E Ratio
  • HLI $33.75
  • ALGN $37.29
  • Revenue Growth
  • HLI 24.80
  • ALGN 1.64
  • 52 Week Low
  • HLI $137.99
  • ALGN $141.74
  • 52 Week High
  • HLI $198.78
  • ALGN $262.87
  • Technical
  • Relative Strength Index (RSI)
  • HLI 65.35
  • ALGN 64.00
  • Support Level
  • HLI $191.39
  • ALGN $188.00
  • Resistance Level
  • HLI $198.78
  • ALGN $205.30
  • Average True Range (ATR)
  • HLI 3.60
  • ALGN 5.88
  • MACD
  • HLI 0.10
  • ALGN 0.45
  • Stochastic Oscillator
  • HLI 80.81
  • ALGN 97.43

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: